Literature DB >> 25342479

Solubility and dissolution enhancement strategies: current understanding and recent trends.

Shashank Jain1, Niketkumar Patel, Senshang Lin.   

Abstract

Identification of lead compounds with higher molecular weight and lower aqueous solubility has become increasingly prevalent with the advent of high throughput screening. Poor aqueous solubility of these lipophilic compounds can drastically affect the dissolution rate and subsequently the drug absorbed in the systemic circulation, imposing a significant burden of time and money during drug development process. Various pre-formulation and formulation strategies have been applied in the past that can improve the aqueous solubility of lipophilic compounds by manipulating either the crystal lattice properties or the activity coefficient of a solute in solution or both, if possible. However, despite various strategies available in the armor of formulation scientist, solubility issue still remains an overriding problem in the drug development process. It is perhaps due to the insufficient conceptual understanding of solubility and dissolution phenomenon that hinders the judgment in selecting suitable strategy for improving aqueous solubility and/or dissolution rate. This article, therefore, focuses on (i) revisiting the theoretical and mathematical concepts associated with solubility and dissolution, (ii) their application in making rationale decision for selecting suitable pre-formulation and formulation strategies and (iii) the relevant research performed in this field in past decade.

Entities:  

Keywords:  Amorphous solid dispersion; bioavailability; dissolution rate; formulation strategies; particle size reduction; poor solubility; salts

Mesh:

Substances:

Year:  2014        PMID: 25342479     DOI: 10.3109/03639045.2014.971027

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

Review 1.  Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles.

Authors:  Nebojša Pavlović; Svetlana Goločorbin-Kon; Maja Ðanić; Bojan Stanimirov; Hani Al-Salami; Karmen Stankov; Momir Mikov
Journal:  Front Pharmacol       Date:  2018-11-08       Impact factor: 5.810

2.  Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.

Authors:  Daniel Real; Stefan Hoffmann; Darío Leonardi; Claudio Salomon; Francisco M Goycoolea
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

3.  Cocrystal Formation of Betulinic Acid and Ascorbic Acid: Synthesis, Physico-Chemical Assessment, Antioxidant, and Antiproliferative Activity.

Authors:  Mirela Nicolov; Roxana M Ghiulai; Mirela Voicu; Marius Mioc; Adina Octavia Duse; Roxana Roman; Rita Ambrus; Istvan Zupko; Elena Alina Moaca; Dorina E Coricovac; Claudia Farcas; Roxana Marcela Racoviceanu; Corina Danciu; Cristina-Adriana Dehelean; Codruta Soica
Journal:  Front Chem       Date:  2019-02-21       Impact factor: 5.221

4.  Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.

Authors:  Ecaterina Bordos; Muhammad T Islam; Alastair J Florence; Gavin W Halbert; John Robertson
Journal:  Mol Pharm       Date:  2019-09-09       Impact factor: 4.939

5.  Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability.

Authors:  Mingfang Wu; Chen Zhong; Yiping Deng; Qian Zhang; Xiaoxue Zhang; Xiuhua Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 6.  Analysis of the Literature and Patents on Solid Dispersions from 1980 to 2015.

Authors:  Jinglu Zhang; Run Han; Weijie Chen; Weixiang Zhang; Ying Li; Yuanhui Ji; Lijiang Chen; Hao Pan; Xinggang Yang; Weisan Pan; Defang Ouyang
Journal:  Molecules       Date:  2018-07-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.